• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Gynecol Obstet Hum Reprod A Snapshot of the Covid-19 Pandemic Among Pregnant Women in France

tetano

Editor, Senior Moderator
J Gynecol Obstet Hum Reprod


. 2020 Jun 4;101826.
doi: 10.1016/j.jogoh.2020.101826. Online ahead of print.
A Snapshot of the Covid-19 Pandemic Among Pregnant Women in France


Gilles Kayem[SUP] 1 [/SUP], Vivien Alessandrini[SUP] 2 [/SUP], Elie Azria[SUP] 3 [/SUP], Julie Blanc[SUP] 4 [/SUP], Caroline Bohec[SUP] 5 [/SUP], Marie Bornes[SUP] 2 [/SUP], Florence Bretelle[SUP] 4 [/SUP], Pierre-Fran?ois Ceccaldi[SUP] 2 [/SUP], Yasmine Chalet[SUP] 2 [/SUP], C?line Chauleur[SUP] 6 [/SUP], Anne-Gael Cordier[SUP] 2 [/SUP], Philippe Deruelle[SUP] 7 [/SUP], Raoul Desbri?re[SUP] 8 [/SUP], Muriel Doret[SUP] 9 [/SUP], Michel Dreyfus[SUP] 10 [/SUP], Marine Driessen[SUP] 2 [/SUP], Marion Fermaut[SUP] 2 [/SUP], Denis Gallot[SUP] 11 [/SUP], Charles Garab?dian[SUP] 12 [/SUP], Cyril Huissoud[SUP] 9 [/SUP], Edouard Lecarpentier[SUP] 13 [/SUP], Dominique Luton[SUP] 2 [/SUP], Olivier Morel[SUP] 14 [/SUP], Franck Perrotin[SUP] 15 [/SUP], Olivier Picone[SUP] 2 [/SUP], Patrick Rozenberg[SUP] 16 [/SUP], Thomas Schmitz[SUP] 2 [/SUP], Lo?c Sentilhes[SUP] 17 [/SUP], Jeremy Sroussi[SUP] 2 [/SUP], Christophe Vayssi?re[SUP] 18 [/SUP], Eric Verspyck[SUP] 19 [/SUP], Alexandre J Vivanti[SUP] 2 [/SUP], Norbert Winer[SUP] 20 [/SUP]



Affiliations

Abstract

Objective: To describe the course over time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in French women from the beginning of the pandemic until mid-April, the risk profile of women with respiratory complications, and short-term pregnancy outcomes.
Methods: We collected a case series of pregnant women with COVID-19 in a research network of 33 French maternity units between March 1 and April 14, 2020. All cases of SARS-CoV-2 infection confirmed by a positive result on real-time reverse transcriptase polymerase chain reaction tests of a nasal sample and/or diagnosed by a computed tomography chest scan were included and analyzed. The primary outcome measures were COVID-19 requiring oxygen (oxygen therapy or noninvasive ventilation) and critical COVID-19 (requiring invasive mechanical ventilation or extracorporeal membrane oxygenation, ECMO). Demographic data, baseline comorbidities, and pregnancy outcomes were also collected.
Results: Active cases of COVID-19 increased exponentially during March 1-31, 2020; the numbers fell during April 1-14, after lockdown was imposed on March 17. The shape of the curve of active critical COVID-19 mirrored that of all active cases. By April 14, among the 617 pregnant women with COVID-19, 93 women (15.1%; 95%CI 12.3-18.1) had required oxygen therapy and 35 others (5.7%; 95%CI 4.0-7.8) had had a critical form of COVID-19. The severity of the disease was associated with age older than 35 years and obesity, as well as preexisting diabetes, previous preeclampsia, and gestational hypertension or preeclampsia. One woman with critical COVID-19 died (0.2%; 95%CI 0-0.9). Among the women who gave birth, rates of preterm birth in women with non-severe, oxygen-requiring, and critical COVID-19 were 13/123 (10.6%), 14/29 (48.3%), and 23/29 (79.3%) before 37 weeks and 3/123 (2.4%), 4/29 (13.8%), and 14/29 (48.3%) before 32 weeks, respectively. One neonate in the critical group died from prematurity.
Conclusion: COVID-19 can be responsible for significant rates of severe acute, potentially deadly, respiratory distress syndromes. The most vulnerable pregnant women, those with comorbidities, may benefit particularly from prevention measures such as a lockdown.

Keywords: COVID 19; lockdown; respiratory complications; risk factors.
 
Back
Top Bottom